title: Safety and efficacy of neo-adjuvant sequential dose-dense chemotherapy doublets combined with trastuzumab in patients with HER-2-positive early stage breast cancer.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Sánchez-Muñoz
authors.forename: Ana Maria
authors.initials: AM
authors.lastname: García-Tapiador
authors.forename: Rosario
authors.initials: R
authors.lastname: Dueñas-García
authors.forename: Ana
authors.initials: A
authors.lastname: Jaén-Morago
authors.forename: Ana Laura
authors.initials: AL
authors.lastname: Ortega-Granados
authors.forename: Esther
authors.initials: E
authors.lastname: Martínez-Ortega
authors.forename: Margarita
authors.initials: M
authors.lastname: Fernández Morales
authors.forename: Mónica
authors.initials: M
authors.lastname: Fernández-Navarro
authors.forename: Capilla
authors.initials: C
authors.lastname: de la Torre Cabrera
authors.forename: Basilio
authors.initials: B
authors.lastname: Dueñas
authors.forename: Crisostomo
authors.initials: C
authors.lastname: Ureña
authors.forename: Julia
authors.initials: J
authors.lastname: Martínez
authors.forename: Francisco
authors.initials: F
authors.lastname: Morales
authors.forename: César
authors.initials: C
authors.lastname: Ramírez-Tortosa
authors.forename: Pedro
authors.initials: P
authors.lastname: Sánchez-Rovira
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D015331:Cohort Studies; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D018734:Genes, erbB-2; D006801:Humans; D008408:Mastectomy / Q000379:methods; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D016019:Survival Analysis; D000068878:Trastuzumab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068878:Trastuzumab